|
1
|
Thorsen F and Tysnes BB: Brain tumor cell
invasion, anatomical and biological considerations. Anticancer Res.
17:4121–4126. 1997.
|
|
2
|
Ohgaki H and Kleihues P: Epidemiology and
etiology of gliomas. Acta Neuropathol. 109:93–108. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Parsons DW, Jones S, Zhang X, et al: An
integrated genomic analysis of human glioblastoma multiforme.
Science. 321:1807–1812. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stupp R, Mason WP, van den Bent MJ, et al
European Organisation for Research and Treatment of Cancer Brain
Tumor and Radiotherapy Groups; National Cancer Institute of Canada
Clinical Trials Group: Radiotherapy plus concomitant and adjuvant
temozolomide for glioblastoma. N Engl J Med. 352:987–996. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Regina Todeschini A and Hakomori SI:
Functional role of glycosphingolipids and gangliosides in control
of cell adhesion, motility, and growth, through glycosynaptic
microdomains. Biochim Biophys Acta. 1780:421–433. 2008. View Article : Google Scholar
|
|
6
|
Miyake M, Nakano K, Itoi SI, Koh T and
Taki T: Motility-related protein-1 (MRP-1/CD9) reduction as a
factor of poor prognosis in breast cancer. Cancer Res.
56:1244–1249. 1996.PubMed/NCBI
|
|
7
|
Huang CI, Kohno N, Ogawa E, Adachi M, Taki
T and Miyake M: Correlation of reduction in MRP-1/CD9 and KAI1/CD82
expression with recurrences in breast cancer patients. Am J Pathol.
153:973–983. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mori M, Mimori K, Shiraishi T, et al:
Motility related protein 1 (MRP1/CD9) expression in colon cancer.
Clin Cancer Res. 4:1507–1510. 1998.PubMed/NCBI
|
|
9
|
Higashiyama M, Doi O, Kodama K, et al:
Immunohistochemically detected expression of motility-related
protein-1 (MRP-1/CD9) in lung adenocarcinoma and its relation to
prognosis. Int J Cancer. 74:205–211. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Halova I, Dráberová L, Bambousková M, et
al: Cross-talk between tetraspanin CD9 and transmembrane adaptor
protein non-T cell activation linker (NTAL) in mast cell activation
and chemotaxis. J Biol Chem. 288:9801–9814. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang CL, Liu D, Masuya D, et al:
MRP-1/CD9 gene transduction downregulates Wnt signal pathways.
Oncogene. 23:7475–7483. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Murayama Y, Shinomura Y, Oritani K, et al:
The tetraspanin CD9 modulates epidermal growth factor receptor
signaling in cancer cells. J Cell Physiol. 216:135–143. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu L, Bäcklund LM, Nilsson BR, et al:
Clinical significance of EGFR amplification and the aberrant
EGFRvIII transcript in conventionally treated astrocytic gliomas. J
Mol Med (Berl). 83:917–926. 2005. View Article : Google Scholar
|
|
14
|
Sugawa N, Yamamoto K, Ueda S, et al:
Function of aberrant EGFR in malignant gliomas. Brain Tumor Pathol.
15:53–57. 1998. View Article : Google Scholar
|
|
15
|
Wang HX, Li Q, Sharma C, Knoblich K and
Hemler ME: Tetraspanin protein contributions to cancer. Biochem Soc
Trans. 39:547–552. 20w11. View Article : Google Scholar
|
|
16
|
Huang X, Li Y, Zhang J, Xu Y, Tian Y and
Ma K: Ganglioside GM3 inhibits hepatoma cell motility via
down-regulating activity of EGFR and PI3K/AKT signaling pathway. J
Cell Biochem. 114:1616–1624. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Y, Huang X, Zhong W, Zhang J and Ma K:
Ganglioside GM3 promotes HGF-stimulated motility of murine hepatoma
cell through enhanced phosphorylation of cMet at specific tyrosine
sites and PI3K/Akt-mediated migration signaling. Mol Cell Biochem.
382:83–92. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nakamura K, Mitamura T, Takahashi T,
Kobayashi T and Mekada E: Importance of the major extracellular
domain of CD9 and the epidermal growth factor (EGF)-like domain of
heparin-binding EGF-like growth factor for up-regulation of binding
and activity. J Biol Chem. 275:18284–18290. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Funakoshi T, Tachibana I, Hoshida Y, et
al: Expression of tetraspanins in human lung cancer cells: frequent
downregulation of CD9 and its contribution to cell motility in
small cell lung cancer. Oncogene. 22:674–687. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Boucheix C and Benoit P: CD9 antigen: will
platelet physiology help to explain the function of a surface
molecule during hemopoietic differentiation? Nouv Rev Fr Hematol.
30:201–202. 1988.PubMed/NCBI
|
|
21
|
Masellis-Smith A and Shaw AR:
CD9-regulated adhesion. Anti-CD9 monoclonal antibody induce pre-B
cell adhesion to bone marrow fibroblasts through de novo
recognition of fibronectin. J Immunol. 152:2768–2777.
1994.PubMed/NCBI
|
|
22
|
Schmidt C, Künemund V, Wintergerst ES,
Schmitz B and Schachner M: CD9 of mouse brain is implicated in
neurite outgrowth and cell migration in vitro and is associated
with the alpha 6/beta 1 integrin and the neural adhesion molecule
L1. J Neurosci Res. 43:12–31. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chernousov MA, Stahl RC and Carey DJ:
Tetraspanins are involved in Schwann cell-axon interaction. J
Neurosci Res. 91:1419–1428. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Murayama Y, Miyagawa J, Shinomura Y, et
al: Significance of the association between heparin-binding
epidermal growth factor-like growth factor and CD9 in human gastric
cancer. Int J Cancer. 98:505–513. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kawashima M, Doh-ura K, Mekada E, Fukui M
and Iwaki T: CD9 expression in solid non-neuroepithelial tumors and
infiltrative astrocytic tumors. J Histochem Cytochem. 50:1195–1203.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Takahashi M, Sugiura T, Abe M, Ishii K and
Shirasuna K: Regulation of c-Met signaling by the tetraspanin
KAI-1/CD82 affects cancer cell migration. Int J Cancer.
121:1919–1929. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Odintsova E, Voortman J, Gilbert E and
Berditchevski F: Tetraspanin CD82 regulates compartmentalisation
and ligand-induced dimerization of EGFR. J Cell Sci. 116:4557–4566.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gustafson-Wagner E and Stipp CS: The
CD9/CD81 tetraspanin complex and tetraspanin CD151 regulate
alpha3beta1 integrin-dependent tumor cell behaviors by overlapping
but distinct mechanisms. PloS One. 8:e618342013. View Article : Google Scholar
|
|
29
|
Nakagawa T, Higashiyama S, Mitamura T,
Mekada E and Taniguchi N: Amino-terminal processing of cell surface
heparin-binding epidermal growth factor-like growth factor
up-regulates its juxtacrine but not its paracrine growth factor
activity. J Biol Chem. 271:30858–30863. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Murayama Y, Miyagawa J, Oritani K, et al:
CD9-mediated activation of the p46 Shc isoform leads to apoptosis
in cancer cells. J Cell Sci. 117(Pt 15): 3379–3388. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jones RB, Gordus A, Krall JA and MacBeath
G: A quantitative protein interaction network for the ErbB
receptors using protein microarrays. Nature. 439:168–174. 2006.
View Article : Google Scholar
|
|
32
|
Lindemann C, Hackmann O, Delic S, Schmidt
N, Reifenberger G and Riemenschneider MJ: SOCS3 promoter
methylation is mutually exclusive to EGFR amplification in gliomas
and promotes glioma cell invasion through STAT3 and FAK activation.
Acta Neuropathol. 122:241–251. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jin W, Xu X, Yang T and Hua Z: p53
mutation, EGFR gene amplification and loss of heterozygosity on
chromosome 10, 17 p in human gliomas. Chin Med J (Engl).
113:662–666. 2000.
|
|
34
|
Cecconi S, Mauro A, Cellini V and
Patacchiola F: The role of Akt signalling in the mammalian ovary.
Int J Dev Biol. 56:809–817. 2012. View Article : Google Scholar
|
|
35
|
Golding SE, Morgan RN, Adams BR, Hawkins
AJ, Povirk LF and Valerie K: Pro-survival AKT and ERK signaling
from EGFR and mutant EGFRvIII enhances DNA double-strand break
repair in human glioma cells. Cancer Biol Ther. 8:730–738. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sarbassov DD, Guertin DA, Ali SM and
Sabatini DM: Phosphorylation and regulation of Akt/PKB by the
rictor-mTOR complex. Science. 307:1098–1101. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Schulze WX, Deng L and Mann M:
Phosphotyrosine interactome of the ErbB-receptor kinase family. Mol
Syst Biol. 1:2005.00082005. View Article : Google Scholar
|
